Nuclear JAK2.
作者信息
Dawson Mark A, Bannister Andrew J, Saunders Lindsay, Wahab Omar-Abdel, Liu Fan, Nimer Stephen D, Levine Ross L, Göttgens Berthold, Kouzarides Tony, Green Anthony R
出版信息
Blood. 2011 Dec 22;118(26):6987-8. doi: 10.1182/blood-2011-10-385278.
Abstract
摘要
相似文献
1
Nuclear JAK2.核JAK2
Blood. 2011 Dec 22;118(26):6987-8. doi: 10.1182/blood-2011-10-385278.
2
Confocal imaging studies cast doubt on nuclear localization of JAK2V617F.共聚焦成像研究对JAK2V617F的核定位提出了质疑。
Blood. 2011 Sep 1;118(9):2633-4. doi: 10.1182/blood-2011-02-336479.
3
Detecting the JAK2 V617F mutation in fresh and 'historic' blood and bone marrow.检测新鲜及“陈旧”血液和骨髓中的JAK2 V617F突变。
Leukemia. 2007 Jul;21(7):1599-602. doi: 10.1038/sj.leu.2404701. Epub 2007 Apr 26.
4
Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals.B细胞和T细胞肿瘤中JAK2的评估：三名个体骨髓中JAK2（V617F）意义未明突变（JMUS）的鉴定。
Acta Haematol. 2007;118(4):209-14. doi: 10.1159/000111532. Epub 2007 Nov 21.
5
The investigation of JAK2 mutation in Chinese myeloproliferative diseases-identification of a novel C616Y point mutation in a PV patient.中国骨髓增殖性疾病中JAK2突变的研究——1例真性红细胞增多症患者中新型C616Y点突变的鉴定
Int J Lab Hematol. 2007 Feb;29(1):71-2. doi: 10.1111/j.1365-2257.2006.00864.x.
6
Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia.骨髓化生的骨髓纤维化患者异基因干细胞移植后Janus激酶2（JAK2）V617F突变的清除情况。
Am J Hematol. 2007 May;82(5):400-2. doi: 10.1002/ajh.20832.
7
Characterization of a highly effective protein substrate for analysis of JAK2(V617F) Activity.用于分析JAK2（V617F）活性的高效蛋白质底物的表征
Exp Hematol. 2007 Nov;35(11):1624-32. doi: 10.1016/j.exphem.2007.07.003. Epub 2007 Aug 30.
8
Absence of JH2 domain mutation of the tyrosine kinase JAK2 in renal cell carcinomas.
Acta Oncol. 2008;47(3):474-6. doi: 10.1080/02841860701499390.
9
Nuclear JAK2: form and function in cancer.核 JAK2：癌症中的形态和功能。
Anat Rec (Hoboken). 2011 Sep;294(9):1446-59. doi: 10.1002/ar.21443. Epub 2011 Aug 1.
10
Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action.
Brain Res Mol Brain Res. 1996 May;38(1):161-5. doi: 10.1016/0169-328x(96)00010-1.
引用本文的文献
1
The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms.髓系癌症中表观遗传靶分子与疗法的演变格局：聚焦急性髓系白血病和骨髓增殖性肿瘤
Leukemia. 2025 May 15. doi: 10.1038/s41375-025-02639-x.
2
Malignant JAK-signaling: at the interface of inflammation and malignant transformation.恶性JAK信号传导：炎症与恶性转化的交汇点
Leukemia. 2025 May;39(5):1011-1030. doi: 10.1038/s41375-025-02569-8. Epub 2025 Mar 26.
3
RNAi-based drug design: considerations and future directions.基于 RNAi 的药物设计：考虑因素和未来方向。
Nat Rev Drug Discov. 2024 May;23(5):341-364. doi: 10.1038/s41573-024-00912-9. Epub 2024 Apr 3.
4
The JAK-STAT pathway at 30: Much learned, much more to do.JAK-STAT 通路 30 年：学无止境，任重道远。
Cell. 2022 Oct 13;185(21):3857-3876. doi: 10.1016/j.cell.2022.09.023.
5
Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation.野生型N-Ras在基底样乳腺癌中过表达，通过激活JAK2诱导IL-8分泌促进肿瘤形成。
Cell Rep. 2015 Jul 21;12(3):511-24. doi: 10.1016/j.celrep.2015.06.044. Epub 2015 Jul 9.
6
The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.两面神转录因子PAX5-JAK2在急性淋巴细胞白血病中的作用
Blood. 2015 Feb 19;125(8):1282-91. doi: 10.1182/blood-2014-04-570960. Epub 2014 Dec 16.
7
JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.JAK2酪氨酸激酶被中心体蛋白Ninein磷酸化并受到其负调控。
Mol Cell Biol. 2015 Jan;35(1):111-31. doi: 10.1128/MCB.01138-14. Epub 2014 Oct 20.
本文引用的文献
1
JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth.JAK蛋白进入细胞核：细胞核内JAK1和JAK2在基因表达及细胞生长中的新作用
Growth Factors. 2011 Dec;29(6):245-52. doi: 10.3109/08977194.2011.614949. Epub 2011 Sep 5.
2
Confocal imaging studies cast doubt on nuclear localization of JAK2V617F.共聚焦成像研究对JAK2V617F的核定位提出了质疑。
Blood. 2011 Sep 1;118(9):2633-4. doi: 10.1182/blood-2011-02-336479.
3
Nuclear JAK2: form and function in cancer.核 JAK2：癌症中的形态和功能。
Anat Rec (Hoboken). 2011 Sep;294(9):1446-59. doi: 10.1002/ar.21443. Epub 2011 Aug 1.
4
Transcriptional control of adrenal steroidogenesis: novel connection between Janus kinase (JAK) 2 protein and protein kinase A (PKA) through stabilization of cAMP response element-binding protein (CREB) transcription factor.转录调控肾上腺甾体生成：Janus 激酶（JAK）2 蛋白与蛋白激酶 A（PKA）之间通过稳定 cAMP 反应元件结合蛋白（CREB）转录因子的新型连接。
J Biol Chem. 2011 Sep 23;286(38):32976-85. doi: 10.1074/jbc.M111.218016. Epub 2011 Aug 1.
5
Controlling nuclear JAKs and STATs for specific gene activation by IFNγ.通过 IFNγ 控制核 JAKs 和 STATs 实现特定基因的激活。
Biochem Biophys Res Commun. 2011 Jul 8;410(3):648-53. doi: 10.1016/j.bbrc.2011.06.047. Epub 2011 Jun 13.
6
When signaling kinases meet histones and histone modifiers in the nucleus.当信号激酶在核内遇到组蛋白和组蛋白修饰酶时。
Mol Cell. 2011 May 6;42(3):274-84. doi: 10.1016/j.molcel.2011.03.022.
7
JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation.JAK2V617F 介导的 PRMT5 磷酸化下调其甲基转移酶活性并促进骨髓增殖。
Cancer Cell. 2011 Feb 15;19(2):283-94. doi: 10.1016/j.ccr.2010.12.020.
8
Cooperative epigenetic modulation by cancer amplicon genes.癌症扩增基因的协同表观遗传调节。
Cancer Cell. 2010 Dec 14;18(6):590-605. doi: 10.1016/j.ccr.2010.11.013.
9
LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease.从一种成体干细胞疾病中发现的胚胎干细胞中 Lif 非依赖性 JAK 信号转导至染色质
Nat Cell Biol. 2011 Jan;13(1):13-21. doi: 10.1038/ncb2135. Epub 2010 Dec 12.
10
JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin.JAK2使组蛋白H3Y41磷酸化，并将HP1α排除在染色质之外。
Nature. 2009 Oct 8;461(7265):819-22. doi: 10.1038/nature08448. Epub 2009 Sep 27.
Zotero 插件